Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City
Preliminary evidence of health care provider support for naloxone prescription as overdose fatality prevention strategy in New York City
复制标题
DOI：
10.1093/jurban/jtg031
复制
发表时间：
2003-06-01
影响因子：
6.6
通讯作者：
Vlahov, D
中科院分区：
文献类型：
--
作者：
Coffin, PO;Fuller, C;Vlahov, D
初步研究表明，纳洛酮(Narcan)是一种短效阿片类拮抗剂，可以通过处方或分发给海洛因使用者来提供，以减少过量服药致死的可能性。我们对纽约市1100名获得处方授权的医疗保健提供者进行了一项随机的邮寄调查，以确定是否愿意给有阿片类药物过量风险的患者开纳洛酮。在回答的363名执业护士、内科医生和医生助理中，33.4%的人会考虑开纳洛酮，29.4%的人不确定。这项初步研究表明，纽约市相当数量的医疗保健提供者会开出纳洛酮来预防阿片类药物过量。
Preliminary research suggests that naloxone (Narcan), a short-acting opiate antagonist, could be provided by prescription or distribution to heroin users to reduce the likelihood of fatality from overdose. We conducted a random postal survey of 1,100 prescription-authorized health care providers in New York City to determine willingness to prescribe naloxone to patients at risk of an opiate overdose. Among 363 nurse practitioners, physicians, and physician assistants responding, 33.4% would consider prescribing naloxone, and 29.4% were unsure. This preliminary study suggests that a substantial number of New York City health care providers would prescribe naloxone for opiate overdose prevention.